Company Snags 68th Spot in Reputation Institute's 12th-annual US RepTrak® 100
WHIPPANY, N.J. /PRNewswire/ -- Bayer U.S. has earned a top ranking in Reputation Institute's 2019 US RepTrak® 100 – the biggest-ever survey measuring the reputation of companies in the country. The results from the 12th annual US RepTrak 100, which measures the public perception of companies based on multiple business drivers, were released Wednesday.
Bayer ranks 68th on this year's list of America's most reputable companies. Bayer is the only life science company to make this year's list.
"A strong corporate reputation has never been more important than it is today," said Raymond F. Kerins, Jr., Senior Vice President of Corporate Affairs for Bayer U.S. "In this era of consistent focus on crucial reputation aspects of business conduct such as ethics, leadership, transparency and workplace equality, it is tremendously gratifying to see Bayer featured on this prestigious list.
"This recognition is a resounding testament to the efforts of all of Bayer's employees in the U.S."
The list is compiled by Reputation Institute – the world's foremost data insights and advisory firm singularly focused on corporate reputation.
Stephen Hahn-Griffiths, chief reputation officer at Reputation Institute, said, "Companies are on trial in the court of public opinion. It's 'reputation judgment day,' when companies are examined more than ever. To avoid risks, companies must know how to proactively manage reputation, deliver on key stakeholder expectations, and mitigate risks by delivering on reputation assurance."
The complete ranking of the 2019 US RepTrak can be found at www.reputationinstitute.com/us-reptrak.
About Reputation Institute
Reputation Institute helps leaders at the world's largest companies build credibility with the people that matter most to them by delivering data-driven insights about how they are truly perceived. We do this with RepTrak®, an unrivaled technology that provides actionable insights across industry, competitor, and company analysis.
Dan Childs, phone +1 973.437.0809